Учебники / Head_and_Neck_Cancer_Imaging
.pdf
156 |
V. F. H. Chong |
management policies. Persistent or residual disease may be due to firstly, a “geographic miss” on the irradiation plan; secondly, the relative radio-insensitivity of the tumor; thirdly, an insufficiently high radiation dose, and fourthly, the time taken to deliver the dose was too long.
Patients are often followed-up clinically at 1- to 2-monthly intervals in the first year, 2- to 3-monthly intervals in the second year and 3- to 4-monthly intervals in the third year. These patients can be seen at 6-monthly intervals subsequently. Tumor recurrence is usually detected by endoscopy and imaging is requested for the assessment of tumor extent (Sham et al. 1992). Imaging is also used to confirm deep recurrences not apparent on endoscopy but suspected on the basis of history and symptomology (Fig. 8.13).
Differentiating fibrosis from tumor recurrence is difficult on CT since the attenuation values of these tissues are similar. Separating tumor recurrence from fibrosis on MRI is only easier if the scar is mature. Early fibrous tissue is hypercellular and produces high signals on T2-weighted images. Both immature scar and tumor show contrast-enhancement on MRI and high signals on T2-weighted images. Mature scar, which is hypocellular, does not show contrastenhancement and is characterized by low signal intensity on T2-weighted images.
The simultaneous dynamic processes of fibrosis and tissue reaction to irradiation often produce a confusing picture.Residual disease or recurrent tumor may be hypointense relative to granulation tissue in the early
stage. Scar tissue may also show high signal intensity in T2-weighted images. Furthermore, areas of high signals on T2-weighted images may be seen in corresponding areas showing no contrast enhancement. Differentiating tumor recurrence from fibrosis, therefore, can be a formidable task (Chong and Fan 1997).
To overcome the above mentioned problems, regular follow-up should be performed. It is important to obtain a baseline study around 6 months after radiation therapy and another scan 6 months later. These studies can be used for comparison with future yearly follow up studies over the next 3 years (and longer if required). A stable appearance can provide reassurance that the abnormality seen is most likely to be due to the effects of radiation.
Positron emission tomography (PET) using 2-[F- 18] fluoro-2-deoxy-D-glucose (FDG) has demonstrated value in detecting NPC recurrence following radiotherapy (Kao et al. 1998; Tsai et al. 2002). The advent of PET CT has provided even more information by co-registering tracer uptake with anatomic information.
8.8.3.2
Treatment Complications
The complications of radiation therapy can be divided into neurological and non-neurological sequelae. Neurological complications include temporal lobe necrosis, encephalomyelopathy and cranial nerve palsies. Non-neurological complications include at-
|
b |
|
Fig. 8.13a,b. NPC with submucosal recurrence.a Axial T1-weighted |
|
MR image shows extensive submucosal recurrence involving |
|
right prevertebral muscle (black arrow), left carotid space (white |
|
arrow) and extension into left posterior cranial fossa (asterisk). |
|
b Coronal contrast-enhanced MR image shows tumor infiltrating |
|
extending through left side of foramen magnum into posterior |
a |
cranial fossa (arrow) |
Neoplasms of the Nasopharynx |
157 |
rophy of salivary glands, muscles of mastication, and radiation associated tumors.
8.8.3.3
Neurological Complications
8.8.3.3.1
Temporal Lobe Necrosis (TLN)
NPC shows high frequencies of skull base erosion and intracranial extension and is frequently associated with perineural infiltration. The natural history of tumor spread requires adequate radiation treatment coverage of the skull base and the middle cranial fossa. Radiation doses below 6000 cGy at conventional 200 cGy daily are inadequate for tumor control. Hence, the effective radiation dose for the treatment
of NPC exceeds the quoted tolerance limit for the neural tissues resulting in a substantial risk of radia- tion-induced brain damage. Lee et al. (1992) reported a 3% cumulative incidence of TLN in her series of 4527 patients. TLN is probably under diagnosed as 39% of patients had only vague symptoms while 16% had none at all. The latent interval ranged from 1.5 to 13 years (median, 5 years).
The inferior and medial portions of both temporal lobes are at risk as they are included in the target volume. Cerebral edema is the earliest radiologic sign. This is followed by foci of necrosis that may be located in the gray matter, white matter or both (Fig. 8.14). White matter lesions are characteristically associated with florid edema while gray matter lesions may show minimal or no edema (Chong et al. 2000). Early lesions may heal completely but ex-
a 
b
|
Fig. 8.14a–c. Radiation-induced temporal lobe necrosis (TLN). a Axial |
|
contrast-enhanced MR image shows heterogeneous enhancing lesion |
|
in left temporal lobe. b Axial T2-weighted MR image shows heteroge- |
|
neous signal intensities in left temporal lobe. Low signal area due to |
|
hemosiderin deposition from hemorrhage associated with TLN (thick |
|
arrow). Note accompanying high signal intensity cerebral edema (thin |
|
arrow). c Coronal contrast-enhanced MR image shows intra-axial het- |
|
erogeneously enhancing left TLN (black arrow). Note tumor recurrence |
c |
in left skull base (white arrow) |
158 |
V. F. H. Chong |
tensive involvement frequently results in temporal lobe atrophy or macrocystic encephalomalacia. With the introduction of conformal and intensity modulated radiation therapy (IMRT), the frequency of TLN should gradually decrease.
The differential diagnosis of TLN includes intracranial tumor recurrence and cerebral metastasis. An important point of distinction is whereas recurrent tumor is almost always an extra-axial lesion, TLN is an intra-axial pathologic process. In addition, NPC with intracranial extension, unlike TLN, is usually not associated with cerebral edema. Cerebral metastases are exceedingly rare in NPC (Leung et al. 1991). In clinical practice, cerebral metastasis is seldom placed high on the list of differential diagnosis. If, there are difficulties in differentiating these entities, other modalities based on functional imaging may provided the additional information required for accurate diagnosis. These techniques include MR spectroscopy and PET imaging.
In recent years, MR spectroscopy is increasingly used to study the metabolic changes in the brain following radiation injury. MR spectroscopy in patients with radiation-induced changes in the temporal lobes showed reduced N-acetyl-aspartate levels and relatively stable creatine levels. However, the choline levels may be increased, normal or reduced. The increase choline levels may mimic the presence of primary brain tumor. However, given the known clinical setting, it is unlikely to confuse TLN with the presence of a primary brain neoplasm (Chong et al. 1999, 2001). In addition to MR spectroscopy, PET CT can be used to separate TLN from tumor recurrence. Brain necrosis typically shows no uptake of tracers while tumor recurrence will demonstrate increased metabolic activity.
8.8.3.3.2
Brainstem Encephalopathy
In the past it was widely known that radiation therapy could damage the brainstem and cervical spinal cord in up to 3% of patients (Mesic et al. 1981). The frequency is now considerably less with improved radiation techniques and shielding. Patients with radiation induced cord injury usually present with clinically unmistakable symptoms and signs of corticospinal tract damage. This major complication has a median
latent interval of 3 years (range 0.4–9 years). There is no effective way of reverting or arresting this pathologic process. The majority of patients will develop severe motor disability (Lee and Yau 1997).
8.8.3.3.3 Cranial Nerves
Cranial nerves are relatively radioresistant. The reported frequencies of radiation-induced palsies range from 0.3% to 6% (Flores et al. 1986; Hoppe et al. 1976). This entity is diagnosed by exclusion, as the involved cranial nerves usually appear radiologically unremarkable. The XIIth cranial nerve is the most commonly affected nerve. The optic nerve is the second most commonly damaged nerve followed by the VIth cranial nerve. The IVth, Vth and VIIth nerves are usually involved as part of the brainstem damage syndrome.
8.8.3.4
Non-neurological Complications
8.8.3.4.1 Salivary Glands
Almost all patients have varying degrees of xerostomia and thickening of saliva. Subsequent development of dental caries is common. Radiologically, almost all salivary glands show atrophy. Imaging not infrequently reveals intense salivary gland enhancement. Rarely, patients show acute parotitis, which may develop rapidly over a few days. With the advent of IMRT, the frequency and severity of radiation induced parotitis has decreased.
8.8.3.4.2
Soft Tissue Fibrosis
Marked soft-tissue fibrosis in the neck is common following irradiation with large fractional doses. Although neck fibrosis per se rarely causes serious functional limitation, it may mask nodal recurrence. When the neck is woody hard, palpation is unreliable and the recommended strategy is to use CT to detect lymphadenopathy.
Trismus due to fibrosis around the temporomandibular joints and adjacent muscles of mastication
Neoplasms of the Nasopharynx |
159 |
can result in feeding difficulties. This may be aggravated by pharyngeal mucositis and stricture.
8.8.3.4.3
Radiation Associated Tumors
The tumor induction potential of ionizing radiation is a well-recognized phenomenon. The term radia- tion-induced tumor is frequently used to describe second tumors appearing within previously irradiated fields. However, ascribing the second tumor as a direct consequence of irradiation is often difficult. This entity is better called radiation-associated tumors (RATs).
The criteria for diagnosing RATs include a history of irradiation; the second neoplasm occurring within irradiation field; a difference in the histology of the second neoplasm from the primary tumor; and finally, an arbitrary latency period of at least 5 years (Cahan et al. 1948).
The frequency of head and neck RATs is unknown although it has been estimated to occur between 0.4% to 0.7% (Steeves and Bataini 1981). The reported types of RATs include sarcomas (Fig. 8.15), meningiomas, schwannomas, gliomas, thyroid tumors and squamous cell carcinomas (Fig. 8.16) (Mark et al. 1993; Rubinstein et al. 1989; Bernstein and Laperriere 1991). The improvement of radiation therapy techniques has contributed to increased survival rates of patients with NPC. We can, therefore, expect to see more long-term complications like RATs (Goh et al. 1999) (Fig. 8.16).
8.9
Other Neoplasms of the Nasopharynx
In comparison with undifferentiated carcinoma, nasopharyngeal adenoid cystic carcinoma is rare (Mukherji and Chong 2004). The vast majority of adenoid cystic carcinomas are found in the salivary glands, the mucosa of the oral cavity, nasal fossa and the paranasal sinuses. This tumor affects patients in the middle age and there is no reported sex predilection. Unlike NPC, patients with adenoid cystic carcinomas rarely present with cervical lymphadenopathy.
Fig. 8.15. Radiation associated tumor (RAT) – parosteal sarcoma. Patient had a history of irradiation for NPC (undifferentiated carcinoma) 11 years previously. Axial CT shows a large dense (asterisk) bone tumor arising from the right pterygoid process
Although lymphoid tissues are normally found in the nasopharynx, primary lymphomas in the nasopharynx are uncommon. These tumors are more commonly seen in conjunction with system disease. Nasopharyngeal lymphomas affect all age groups but are more commonly encountered in middle and old age. The majority of these tumors belong to the non-Hodgkin group. Nasopharyngeal involvement is usually detected during the staging process of known disease elsewhere.
Plasma cell neoplasms can be grouped into three categories: multiple myeloma,plasmacytoma of bone, and extramedullary plasmacytoma. Extramedullary plasmacytomas account for approximately 20% of all plasma cell neoplasms and 80% of these lesions are found in the head and neck. Plasmacytomas are most commonly seen in the sixth and seventh decades and have an 80% male preponderance. Plasmacytomas are most frequently seen in the upper airways such as the epiglottis, larynx and nasopharynx (Ching et al. 2002). Approximately 30% of patients with extramedullary plasmacytoma will have systemic disease after 20 years.
160 |
V. F. H. Chong |
a 
b
|
Fig. 8.16a–c. RAT: squamous cell carcinoma. Patient had a his- |
|
tory of irradiation for NPC (undifferentiated carcinoma) 7 years |
|
previously. a Axial contrast-enhanced MR image shows extensive |
|
permeative signal changes in skull base. b Axial contrast-enhanced |
|
MR image shows large RAT squamous cell carcinoma destroying |
|
right left temporal bone. Note tumor invasion of right cerebellum |
|
(arrow). c Coronal contrast-enhanced MR image shows RAT in- |
|
volving right temporal bone (white arrow) and right cerebellum |
c |
(black arrow) |
References
Ahmad A, Stefani S (1986) Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients. J Surg Oncol 33:194–197
Bernstein M, Laperriere N (1991) Radiation-induced tumors of the nervous system. In: Gutin PH, Leibel SA, Sheline GE (eds) Radiation injury to the nervous system. Raven Press, New York, pp 455–472
Cahan WG, Woodward HG, Higinbotham NL, Stewart FW, Coley L (1948) Sarcoma arising in irradiated bone: report of eleven cases. Cancer 1:3–29
Chen MK, Chen TH, Liu JP, et al. (2004) Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer 100:2160–2166
Cheng SH, Tsai SYC, Yen KL, et al. (2005) The hypothesis of dissemination for Stage I-III nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 61:456–465
Ching ASC, Khoo JBK, Chong VFH (2002) CT and MR imaging of solitary extramedullary plasmacytoma of the nasal tract. AJNR 23:1632–1636
Chong VFH (1996) Trigeminal neuralgia in nasopharyngeal carcinoma. J Laryngol Otol 110:394–396
Chong VFH (1997) Masticator space in nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 106:979–982
Chong VFH, Fan YF (1996a) Maxillary nerve involvement in nasopharyngeal carcinoma. AJR Am J Roentgenol 167:1309–1312
Chong VFH, Fan YF (1996b) Skull base erosion in nasopharyngeal carcinoma: Detection by CT and MRI. Clin Radiol 51:625–631
Chong VFH, Fan YF (1997) Detection of recurrent nasopharyngeal carcinoma: CT vs MR imaging. Radiology 202:453– 470
Neoplasms of the Nasopharynx
Chong VFH, Fan YF (1998) Hypoglossal nerve palsy in nasopharyngeal carcinoma. Eur Radiol 8:939–945
Chong VFH, Fan YF, Khoo JBK (1995a) Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Eur J Radiol 21:100–105
Chong VFH, YF Fan, KH Toh, Khoo JBK (1995b) MRI and CT features of nasopharyngeal carcinoma with maxillary sinus involvement. Australas Radiol 39:2–9
Chong VFH, Fan YF, Khoo JBK (1996a) Nasopharyngeal carcinoma with intracranial spread: CT and MRI characteristics. J Comput Assist Tomogr 20:563–639
Chong VFH, Fan YF, Khoo JBK (1996b) MRI features of cervical nodal necrosis in metastatic disease. Clin Radiol 51:103–109
Chong VFH, Fan YF, Mukherji SK (1998) Nasopharyngeal carcinoma. Sem Ultrasound CT MR 19:449–462
Chong VFH, Rumpel H, Aw YS, Ho GL, Fan YF, Chua EJ (1999) Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: proton MR spectroscopic findings. Int J Radiat Oncol Biol Phys 45:699–705
Chong VFH, Fan YF, Mukherji SK (2000) Radiation-induced temporal lobe changes: CT and MR imaging characteristics. AJR Am J Roentgenol 175:431–436, 89
Chong VFH Rumpel H, Fan YF, Mukherji SK (2001) Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 11:317–324 Chong VFH, Khoo JBK, Fan YF (2004a) Nasopharynx and skull
base. Neuroimag Clin North Am 14:695–719
Chong VFH, Zhou JY, Khoo JBK, J Huang, Lim TK (2004b) Tumor volume measurement in tongue carcinoma. Int J Radiat Oncol Biol Phys 59:59–66
Chong VFH, Zhou JY, Khoo JBK, J Huang, Lim TK (2004c) Tumor volume measurement in nasopharyngeal carcinoma. Radiology 231:914–921
Chua D, Sham J, Kwong D, Tai K, et al. (1997) Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 39:711–719
Curtin HD, Hirsch WL (1991) Base of the skull. In: Atlas SW (ed) Magnetic resonance imaging of the brain and spine. Raven Press, New York, pp 669–707
Flores AD, Dickson RI, Riding K, Coy P (1986) Cancer of the nasopharynx in British Columbia. Am J Clin Oncol 9:281– 291
Goh YH, Chong VFH, Low WK (1999) Temporal bone tumours in patients irradiated for nasopharyngeal neoplasms. J Laryngol Otol 113:222–228
Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH (2004) The process for continuous improvement of the TNM classification. Cancer 100:1–5
Green FL, Page D, Morrow M, Balch C, Haller D, Fritz, Fleming I (eds) (2002) AJCC cancer staging manual 6th edn. Springer, New York
Hoppe RT, Goffinet DR, Bagshaw MA (1976) Carcinoma of the nasopharynx: eighteen years’ experience with megavoltage radiation therapy. Cancer 37:2605–2612
Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC (1998) Detection of recurrent or persistent nasopharyngeal carcinoma after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 16:3550–3355
Lee AWM, Law SCK, Ng SH et al. (1992) Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985:
161
late complications following megavoltage irradiation. Br J Radiol 65:918–928
Lee AWM, Foo W, Poon YF, et al. (1996) Staging nasopharyngeal carcinoma: evaluating of N-staging by Ho and UICC/ AJCC systems. Clin Oncol 8:146–154
Lee AWN, Yau TK (1997) Complications of radiotherapy. In: Chong VFH, Tsao SY (eds) Nasopharyngeal carcinoma. Armour, Singapore, pp 114–127
Leung SF, Teo PM, Shiu W, Tsao SY, Leung WT (1991) Clinical features and management of distant metastases of nasopharyngeal carcinoma. J Otolaryngol 20:27–29
Lu TX, Mai WY, The BS, et al. (2001) Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy. Int J Radiat Oncol Biol Phys 51:589–598
Mark RJ, Bailet JW, Poen J, Tran LM, Calcaterra TC, Abemayor E, Fu YS, Parker RG (1993) Post-radiation sarcoma of the head and neck. Cancer 72:887–893
Mesic JB, Fletcher GH Goepfert H (1981) Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 7:447–452
Mukherji SK, Chong V (2004) Atlas of head and neck imaging. Thieme, New York
Mukherji SK, Pillsbury HR, Castillo M (1997) Imaging squamous cell carcinomas of the upper aerodigestive tract: what clinicians need to know. Radiology 205:629–646
Neel HM (1986) Malignant neoplasm of the nasopharynx. In: Schuller DE (ed) Otolaryngology: head and neck surgery, vol 2. CV Mosby, St Louis, p 1401
Ng SH, Chang TC, Ko SF, et al. (1997) Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology 39:741– 746
Nielson NH, Mikkelsen F, Hansen JP (1977) Nasopharyngeal cancer in Greenland: the incidence in an arctic Eskimo population. Acta Pathol Microbiol Scand 85:850–858
Parkin DM, Whelan DL, Ferley J, et al. (eds) (1997) Cancer incidence in five continents, vol. VII. IARC, Lyon, No 143
Roh JL, Sung MW, Kim KH, et al. (2004) Nasopharyngeal carcinoma with skull base invasion: A necessity of staging subdivision. Am J Otolaryngol 25:26–32
Rubinstein AB, Reichenthal E, Borohov H (1989) Radiationinduced schwannomas. Neurosurgery 24:929–932
Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shamugaratnam K (2004) Trends in cancer incidence in Singapore 1968–2002. Singapore Cancer Registry, Singapore
Sham JST, Wei WI, Zong YS, et al. (1990a) Detection of subclinical nasopharyngeal carcinoma by fiberoptic endoscopy and multiple biopsies. Lancet 335:371–374
Sham JST, Choy D, Wei WI (1990b) Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys 19:929–933
Sham JST, Cheung YK, Chan FL, et al. (1990c) Nasopharyngeal carcinoma: pattern of skeletal metastases. Br J Radiol 63:202–205
Sham JST, Cheung YK, Choy D, Chan FL Leong LLY (1991a) Nasopharyngeal carcinoma: CT evaluation of patterns of tumor spread. AJNR 12:265–270
Sham JST, Cheung YK, Choy D, et al. (1991b) Cranial nerve involvement and base of skull erosion in nasopharyngeal carcinoma. Cancer 68:422–426
Sham JST, Choy D, Wei WI, et al. (1992) Value of clinical followup for local nasopharyngeal carcinoma relapse. Head Neck 14:208–217
162
Shanmugaratnam K, Chan SH, de-The G, et al. (1979) Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology, survival rates and other biological characteristics. Cancer 44:1029–1044
Sobin LH (2003) TNM: evolution and relation to other prognostic factors. Semin Surg Oncol 21:3–7
Sobin LH, Wittekind Ch (eds) (2002) UICC TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
Steeves RA, Bataini JP (1981) Neoplasms induced by megavoltage radiation in the head and neck region. Cancer 47:1770–1774
Su CY, Lui CC (1996) Perineural invasion of the trigeminal nerve in patients with nasopharyngeal carcinoma. Cancer 78:2063–2069
V. F. H. Chong
Sze WM, Lee AWM,Yau TK, et al. (2004) Primary tumor volume of nasopharyngeal carcinoma: prognostic significance of local control. Int J Radiat Oncol Biol Phys 59:21–27
Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC (2002) Detection of recurrent nasopharyngeal carcinoma with positron tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 128:279–282
van der Laan BF, Baris G, Gregor RT, Hilgers FJ, Balm AJ (1995) Radiation-induced tumors of the head and neck. J Laryngol Otol 109:346–349
Willner J, Baier K, Pfreunder L, et al. (1999) Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncol 38:1025–1030
Parapharyngeal Space Neoplasms |
163 |
9Parapharyngeal Space Neoplasms
Robert Hermans and Davide Farina
CONTENTS
9.1Introduction 163
9.2Anatomy 163
9.2.1 Fascial Layers and Compartments 163
9.2.2Radiological Anatomy 165
9.3 |
Imaging of Parapharyngeal Space Lesions 166 |
9.3.1 |
Primary Lesions of the Parapharyngeal Space 166 |
9.3.2.1Prestyloid Lesions 166
9.3.2.2Retrostyloid Lesions 169
9.3.2 |
Secondary Lesions of the Parapharyngeal Space 170 |
|
References 174 |
9.1 Introduction
The parapharyngeal space (PPS) is a deep space of the neck shaped as a tilted up pyramid with its base attaching to the skull base and the apex reaching the level of the hyoid bone, and almost exclusively containing fat. Primary neoplasms arising in this space are quite rare, accounting for only 0.5% of all head and neck tumors (Olsen 1994; Miller et al. 1996; Pang et al. 2002), whereas the PPS is more commonly displaced or infiltrated by lesions arising in the adjacent spaces, including the pharyngeal mucosal, masticator, parotid, and retropharyngeal spaces. Approximately 70%–80% of the tumors originating from the PPS itself are benign (Luna-Ortiz et al. 2005).
Small tumors of the PPS, with a size of less than 2.5 cm, are often incidental findings. Larger tumors produce aspecific signs and symptoms, including sore throat, ear fullness, dysphagia and, less frequently, jaw pain combined with cranial nerves palsy. These last two symptoms may be caused by a ma-
R. Hermans, MD, PhD
Professor, Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
D. Farina, MD
Department of Radiology, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, BS, Italy
lignant lesion. Clinical assessment of tumors in this region is often difficult, commonly causing a delay between the onset of clinical manifestations and the diagnosis. Bulging of the lateral nasopharyngeal wall may be appreciated, associated with displacement of the soft palate and palatine tonsil. When a PPS lesion grows laterally, facial swelling may result at the level of the parotid or submandibular region. Rarely, the mandible will be displaced by a slowly growing tumor (Farina et al. 1999).
Physical examination may not allow differentiation between a PPS neoplasm and a parotid gland lesion originating in the deep lobe.Before the advent of crosssectional imaging techniques, such as CT and MR, treatment was performed via a transparotid approach. Nowadays, when a CT or MR study demonstrates the lesion to be in the PPS, most patients are operated via a transcervical approach, with or without resection of the deep lobe of the parotid gland. In large tumors, mandibulotomy may be required to remove the tumor. In selected small tumors, a transoral approach may be sufficient. The use of imaging studies has resulted in a significant decrease of transient or permanent damage to the facial nerve (Stell et al. 1985; Olsen 1994; Miller et al. 1996; Luna-Ortiz et al. 2005).
Lesions arising from the adjacent spaces displace the PPS in a particular way, allowing the radiologist to identify precisely the space of origin. Combining the imaging characteristics of the lesion with a limited space-specific differential diagnosis often allows a precise diagnosis. Knowledge of the anatomy is, therefore, the key to unlock the PPS and its related spaces.
9.2 Anatomy
9.2.1
Fascial Layers and Compartments
Medially, the PPS is in close contact with the pharyngeal mucosal space, bordered by the middle layer of
164 |
R. Hermans and D. Farina |
the deep cervical fascia (also known as buccopharyngeal fascia), which curves around the posterior and lateral side of the pharyngeal mucosal space, surrounding the constrictor muscles (Figs. 9.1 and 9.2). Superiorly, the pharyngeal constrictor muscle does not reach the skull base; at that level, the lumen of the nasopharynx is held open by the thick pharyngobasilar fascia. This fascia lies within the middle layer of the deep cervical fascia. The pharyngobasilar fascia is interrupted at the level of the sinus of Morgagni, an opening through which the cartilaginous part of the Eustachian tube and the levator veli palatini muscle enter the nasopharynx. This area should be carefully inspected on imaging studies of the nasopharynx, as it is a common route of spread for nasopharyngeal carcinomas from the mucosal space to the skull base (see Chap. 8). Just posterior to the Eustachian tube is the fossa of Rosenmüller, a mucosal recess where most of the nasopharyngeal carcinomas arise.
The superficial layer of the deep cervical fascia is lateral to the PPS, separating this space from the masticator space. This fascia curves around the medial surface of the pterygoid muscles and extends from the mandible to the skull base, where it attaches just medial to the foramen ovale. As a consequence, the mandibular nerve (V3), as it courses through this foramen, directly enters the masticator space.
In its posterolateral portion, the PPS is in contact with the deep lobe of the parotid gland. The existence of a fascial layer at this level is controversial.
The anterior border of the PPS is the pterygomandibular raphe. Inferiorly, the PPS gradually becomes narrower and ends at the level of the hyoid bone and superior margin of the submandibular salivary gland.
The posterior border of the PPS is the most complex and controversial; different descriptions are found in the literature. Some authors consider the PPS completely separate from the more posterior carotid space: the anterior surface of the carotid sheath (made up of the three layers of deep cervical fascia) draws the borderline between the two spaces. From a radiological point of view such a separation allows a precise and reliable space-specific differential diagnosis (Som and Curtin 1995). Others, in contrast, consider the carotid sheath and, consequently, the carotid space to be part of the PPS (Mukherji and
Castillo 1998).
Three more fascial structures are described, acting as anatomical landmarks subdividing the PPS. The tensor-vascular-styloid fascia (TVS) is a layer that extends from the inferior border of the tensor veli palatini muscle, posterolaterally and inferiorly to the styloid process and muscles (Fig. 9.2). Anteriorly, it reaches the pterygomandibular raphe and there-
a 
b
Fig. 9.1a,b. Axial T1-weighted spin-echo image (a) at the level of the soft palate. The boundaries of the parapharyngeal space (PPS) (including prestyloid and retrostyloid compartment) are indicated by arrows and arrowheads on the right. On the left, the adjacent spaces are labeled: 1, pharyngeal mucosal space; 2, masticator space; 3, parotid space; 4, retropharyngeal/prevertebral space. b Coronal T1-weighted spin-echo images through prestyloid compartment of the PPS. Inferiorly, this space is closed by the submandibular gland (5), while superiorly, it reaches the skull base (6). The foramen ovale (arrow), through which exits the mandibular nerve, communicates with the masticator space. The styloglossal muscles run through the PPS (arrowheads)
Parapharyngeal Space Neoplasms |
|
|
|
165 |
Pterygoid process |
Masticator space |
Mandible |
||
Tensor veli |
|
|
|
|
palatini muscle |
|
|
|
Superfi cial layer of |
|
|
|
|
deep cervical fascia |
Eustachian tube |
|
|
|
Tensor-vascular-styloid |
|
|
|
|
|
Levator veli |
|
|
|
fascia |
|
|
|
|
|
palatini muscle |
|
|
|
|
Pharyngobasilar |
|
|
|
Stylopharyngeal fascia |
fascia |
|
|
|
|
Buccopharyngeal |
|
|
|
|
fascia |
|
|
|
Parotid gland |
Alar fascia |
|
|
|
(deep lobe) |
Prevertebral fascia |
|
|
|
Styloid process |
|
|
|
|
|
Retropharyngeal |
|
|
|
Internal jugular vein |
lymph node |
|
|
|
|
|
|
|
|
|
Charpy’s fascia |
|
|
|
Digastric muscle |
|
|
|
(posterior belly) |
|
|
|
|
|
|
|
|
|
|
Mastoid process |
Sympathetic chain |
Internal carotid |
Vagal nerve |
Deep layer of deep |
|
|
artery |
|
|
cervical fascia |
Fig. 9.2. Topographical anatomy of the PPS in the axial plane, including the different fascial layers at this level
fore it closes the gap between the skull base, the tensor veli palatini muscle and the styloid process (Som and Curtin 1995). The stylopharyngeal fascia splits on a coronal plane connecting the styloid process to the pharyngobasilar fascia, at the level of the fossa of Rosenmüller. In this same site a third layer, Charpy’s fascia, also known as the ‘cloison sagittale’, arises, oriented on a sagittal plane and posteriorly reaching the prevertebral fascia where it attaches to the lateral cervical processes.
The TVS fascia allows further subdivision of the parapharyngeal space into two compartments: the prestyloid compartment, lying between the pterygoid muscles and the TVS fascia, and the retrostyloid compartment, just medial to the TVS fascia itself and including the carotid space (Maroldi et al. 1994;
Nasser and Attia 1990).
The PPS mainly contains fat tissue and loose connective tissue. In the prestyloid compartment ectopic minor salivary glands and vascular structures (pharyngeal ascending and internal maxillary artery, pharyngeal venous plexus) are found. The retrostyloid PPS contains the internal carotid artery (ICA), the internal jugular vein (IJV), the cranial nerves IX–XII, and the sympathetic plexus. Lymph nodes of the deep cervical chain, known as the jugulodigastric lymph nodes, are present in the retrostyloid compartment, below the level of the posterior belly of the digastric muscle (Grégoire et al. 2003).
9.2.2
Radiological Anatomy
When dealing with pathology at the level of the PPS, MRI has an advantage over CT because of its higher contrast resolution. CT better demonstrates subtle bone erosion. However, MR yields unique information about the medullary bone, which normally has a hyperintense signal on the unenhanced T1-weighted images (due to its fatty content). This signal will become hypointense on the same sequence when the medullary bone is replaced by neoplastic tissue. This signal decrease is a very sensitive sign for neoplastic infiltration, but it is rather aspecific, because edema and inflammatory bone reactions also cause a signal decrease in the medullary bone on T1-weighted images.
In the axial plane the prestyloid compartment of the PPS is recognized as a triangular fat-filled space (Fig. 9.1) with maximum width at the level of the soft palate. While CT is unable to display the pharyngobasilar fascia, this fascia is visible on MRI as a hypointense line (Fig. 9.3).
The sinus of Morgagni is not visible with MR, but the Eustachian tube, particularly at the torus tubarius, where it opens in the nasopharyngeal lumen, can be used as an anatomical landmark.
The TVS, stylopharyngeal and Charpy’s fascia can not be routinely identified on MR. Their course can be
